Orexo AB (FRA:C5G)
€ 1.078 0.203 (23.2%) Market Cap: 37.46 Mil Enterprise Value: 78.99 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 53/100

Orexo AB Capital Markets Day Transcript

Mar 17, 2020 / 12:30PM GMT
Release Date Price: €3.75 (-5.90%)
Nikolaj SÃ;rensen;publ;President;CEO
Orexo AB

¸ - ()-&

Welcome to Orexo's Capital Markets Day. And to say the least, this has not really developed as we had planned. The positive part is that we have more participants than we've had at any other Capital Markets Day, but they're not here in the room with me, but I just heard we have more than 100 people who are connecting in through online means. And I'm pretty sure, there are a lot of people who have -- don't have anything better to do today than to listen to one of the most exciting Swedish pharmaceutical companies, at Orexo. It does sounds like an impressive number, but I'll also, actually, have a special welcome to our field force in the U.S. because we have asked the field force to join us for this call, because you see it's a tremendous opportunity to present our digital therapies, and how we're going to work with that. And I will come back to that a little later. But both investors, who are here in the room, I will say we are within the limits of -- in the U.S. with 10 people in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot